Anthem Blue Cross denied my 9-year-old daughter's pre-auth for an MRI to diagnose pediatric epilepsy claiming an EEG was 'sufficient first-line imaging' even though her pediatric neurologist explicitly ordered the MRI to rule out a structural lesion. Won the urgent external review in 11 days under the ACA-mandated process by citing the AAN practice parameters and the NCCN imaging guidance. The three-step framework that flips pre-auth denials

Posting this because pre-authorization denials on diagnostic imaging are one of the most common and most successfully appealed health insurance disputes, and the framework for reversal is much more accessible than most parents realize. Background: my 9-year-old daughter started having focal seizures with secondary generalization in February 2026. After two ER visits and a confirmatory EEG showing right temporal lobe epileptiform activity, her pediatric neurologist at Lurie Children's in Chicago ordered a brain MRI with and without contrast to rule out a structural lesion (cortical dysplasia, low-grade tumor, mesial temporal sclerosis, AVM) as the underlying cause. The neurologist documented in the order that without MRI characterization of the seizure focus we could not appropriately stage the diagnostic workup or develop a treatment plan beyond empiric anticonvulsant therapy.

Anthem Blue Cross denied the pre-authorization on the basis that an EEG had already been performed and was "sufficient first-line imaging for new-onset seizure disorder" and that MRI was "not medically necessary at this stage of the diagnostic workup." The denial was issued through Carelon Medical Benefits Management (formerly AIM Specialty Health), the radiology benefit management vendor Anthem uses for imaging pre-auth review. The reviewing physician was a board-certified internist (not a pediatric neurologist) who never spoke with the treating neurologist and who applied an adult-focused imaging guideline that does not reflect pediatric epilepsy workup standards. This is a textbook example of how RBM vendors apply algorithmic denials that ignore subspecialty practice standards.

The three-step framework that flips pre-auth denials. First, the peer-to-peer review request. Federal law and most state insurance regulations require the carrier to make a peer-to-peer review available within 24 to 72 hours of request, with a physician of the same specialty as the treating provider. Demand the peer-to-peer in writing, identify the treating physician's specialty (pediatric neurology in our case), and require that the reviewing physician be board-certified in the same subspecialty. Carelon initially offered a general pediatrician for the peer-to-peer which we rejected. They eventually produced a pediatric neurologist 6 days later. The peer-to-peer did not resolve the denial because the reviewer cited an internal Carelon guideline that conflicted with the AAN practice parameters.

Second, the urgent external review under the ACA. Section 2719 of the ACA requires all non-grandfathered group health plans and individual market plans to provide an external review process for adverse benefit determinations, with urgent review available where delay would jeopardize the enrollee's health. Pediatric seizure workup qualifies as urgent on its face. The external review request must be submitted to the appropriate state external review organization (in Illinois, the Illinois Department of Insurance assigns an Independent Review Organization). The IRO physician must be a board-certified specialist in the relevant field, must not have any affiliation with the carrier or the RBM vendor, and must issue a decision binding on the carrier within 72 hours for urgent reviews. We submitted the external review request on day 5 after the initial denial. Third, the supporting documentation packet. The packet must include the treating neurologist's detailed clinical rationale, the EEG findings, the relevant AAN practice parameters (Hirtz et al. 2003 "Practice parameter: evaluating a first nonfebrile seizure in children" and the 2007 update), the NCCN imaging guidance where applicable, and any institutional protocols from the treating facility. The IRO physician (a pediatric epileptologist at a Midwest academic medical center) reversed the denial in 11 days finding that MRI was clearly indicated under the AAN practice parameters for new-onset focal seizure with EEG abnormalities. The MRI was performed 5 days after the reversal and identified a small right temporal cortical dysplasia which directly informed her surgical evaluation. The external review process is mandatory, fast, and binding on the carrier. Most parents never use it because they do not know it exists.